Ticker
XFORCompany Name
X4 PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 17M | $ 5.77M | $ 0 | -33.92% |
3/31/2025 | $ 21.71M | $ 294K | $ 0 | -1.35% |
12/31/2024 | $ 46.78M | $ 294K | $ 0 | -0.63% |
9/30/2024 | $ 47.29M | $ 256K | $ 0 | -0.54% |
6/30/2024 | $ 109.78M | $ -25K | $ 0 | 0.02% |
3/31/2024 | $ 183.05M | $ 69.15M | $ 0 | -37.78% |
12/31/2023 | $ 220M | $ 68.71M | $ 0 | -31.23% |
9/30/2023 | $ 132.16M | $ 129.26M | $ 0 | -97.8% |
6/30/2023 | $ 172.65M | $ 181.08M | $ 0 | -104.88% |
3/31/2023 | $ 188.2M | $ 111.72M | $ 0 | -59.36% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for X4 PHARMACEUTICALS INC is calculated as follows: (-1 * CF - Equity [ $ 60.44M ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 97.88M ]
(=) Payout Yield [ -61.75% ]
Minimum
Dec 31, 2021
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.1% |